New Vision Research Continues to Impact Research Through Seed Funding.
New Vision Research Continues to Impact Research Through Seed Funding. Charleston, South Carolina, June 5, 2024 – John Kauwe Ph.D., a 2013 CCAD awardee shares how CCAD made a difference in his research career. Kauwe is the president of BYU-Hawaii and owner of Halia Therapeutics, a company that discovers and develops novel therapies to improve the
New Vision Research Continues to Impact Research Through Seed Funding. Read More »
